Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03712647
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
SIH | PROGESTERONE-11-ALPHA-OL-HEMISUCCINATE | H | 1DBM | 0.79 | |
20E | (2beta,3beta,5beta,22R)-2,3,14,20,22,25- hexahydroxycholest-7-en-6-one | A,D | 2R40 | 0.74 | |
SIM | SIMVASTATIN | A,B,C,D | 1HW9 | 0.85 | |
KH1 | 5-(2-{1-[1-(4-ETHYL-4-HYDROXY-HEXYLOXY)- ETHYL]-7A-METHYL-OCTAHYDRO-INDEN- 4-YLIDENE}-ETHYLIDENE)-4-METHYLENE- CYCLOHEXANE-1,3-DIOL | A | 1IE8 | 0.75 | |
0AS | asiatic acid | A | 2QN1 | 0.75 | |
PLO | (3BETA)-3-HYDROXYPREGN-5-EN-20- ONE | A | 1Q20 | 0.79 | |
DL4 | (14beta,17alpha,25R)-3-oxocholest- 4-en-26-oic acid | A | 3GYT | 0.75 | |
MOU | A,B | 2NPF | 0.7 | ||
FUA | FUSIDIC ACID | A | 1QCA | 0.77 | |
FUA | FUSIDIC ACID | A,B,C,D,E,F, G,H,I,J,K,L | 1Q23 | 0.77 | |
FUA | FUSIDIC ACID | A,B | 2VUF | 0.77 | |
1CA | DESOXYCORTICOSTERONE | A,B | 1Y9R | 0.72 | |
1CA | DESOXYCORTICOSTERONE | A,B,C | 2ABI | 0.72 | |
1CA | DESOXYCORTICOSTERONE | A | 2Q3Y | 0.72 | |
1CA | DESOXYCORTICOSTERONE | A | 2AA7 | 0.72 | |
0MA | maslinic acid | A | 2QN2 | 0.77 | |
2OB | CHOLESTERYL OLEATE | A | 2OBD | 0.81 | |
BIV | 21-NOR-9,10-SECOCHOLESTA-5,7,10(19)- TRIENE-1,3,25-TRIOL, 20-(4-HYDROXY- 4-METHYLPENTYL)-, (1A,3B,5Z,7E) | A | 2HCD | 0.73 | |
GR4 | H,I | 1AWF | 0.72 | ||
CBO | CARBENOXOLONE | A,B,C,D | 1HDC | 0.74 | |
CBO | CARBENOXOLONE | A,B,C,D | 2BEL | 0.74 | |
VD5 | (1R,3R,7E,17E)-17-(5-hydroxy-1,5- dimethylhexylidene)-2-methylene- 9,10-secoestra-5,7-diene-1,3-diol | A | 2O4R | 0.71 | |
VD2 | 5-{2-[1-(5-HYDROXY-1,5-DIMETHYL- HEXYL)-7A-METHYL-OCTAHYDRO-INDEN- 4-YLIDENE]-ETHYLIDENE}-2-METHYL- CYCLOHEXANE-1,3-DIOL | A | 1RKH | 0.74 | |
CLL | CHOLESTERYL LINOLEATE | A,B | 1CLE | 0.81 | |
TES | TESTOSTERONE | A | 1JTV | 0.74 | |
TES | TESTOSTERONE | A | 2Q7L | 0.74 | |
TES | TESTOSTERONE | A | 2Q7I | 0.74 | |
TES | TESTOSTERONE | A,B | 1J96 | 0.74 | |
TES | TESTOSTERONE | A | 2Q7K | 0.74 | |
TES | TESTOSTERONE | A,B | 1Q13 | 0.74 | |
TES | TESTOSTERONE | H | 1I9J | 0.74 | |
TES | TESTOSTERONE | A,B | 1AFS | 0.74 | |
TES | TESTOSTERONE | H | 1VPO | 0.74 | |
TES | TESTOSTERONE | A | 2Q7J | 0.74 | |
TES | TESTOSTERONE | A,B | 3BUR | 0.74 | |
TES | TESTOSTERONE | A | 2AM9 | 0.74 | |
COV | (1S,3R,5Z,7E,14beta,17alpha)-17- [(2S,4S)-4-(2-hydroxy-2-methylpropyl)- 2-methyltetrahydrofuran-2-yl]-9,10- secoandrosta-5,7,10-triene-1,3- diol | A | 3CS4 | 0.75 | |
OCC | 2ALPHA-(3-HYDROXYPROPOXY)-1ALPHA,25- DIHYDROXYVITAMIN D3 | A | 2HAR | 0.74 | |
SXN | Salinixanthin | A,B | 3DDL | 0.71 | |
17H | 17-HYDROXY-18A-HOMO-19-NOR-17ALPHA- PREGNA-4,9,11-TRIEN-3-ONE | A | 2AMB | 0.78 | |
NDR | (14beta,17alpha)-17-ethynyl-17- hydroxyestr-4-en-3-one | A,B | 1SQN | 0.7 | |
NDR | (14beta,17alpha)-17-ethynyl-17- hydroxyestr-4-en-3-one | A,B | 2W8Y | 0.7 | |
DEX | DEXAMETHASONE | A,D | 1M2Z | 0.71 | |
DEX | DEXAMETHASONE | A,B,C,D | 1P93 | 0.71 | |
NOG | 13-BETA-ETHYL-17-ALPHA-ETHYNYL- 17-BETA-HYDROXYGON-4-EN-3-ONE | A | 1LHV | 0.7 | |
NOG | 13-BETA-ETHYL-17-ALPHA-ETHYNYL- 17-BETA-HYDROXYGON-4-EN-3-ONE | A,B | 3D90 | 0.7 | |
JB1 | (1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)- 1-[(2R,3S)-3-(2-hydroxyethyl)heptan- 2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro- 1H-inden-4-ylidene]ethylidene]- 4-methylidene-cyclohexane-1,3-diol | A | 2ZXM | 0.72 | |
GR3 | 3-ACETOXY-17-(1-FORMYL-5-METHYL- 3-OXO-HEX-4-ENYL)-16-HYDROXY-4,10,13,14- TETRAMETHYL-2,3,4,5,6,9,10,11,12,13,14,15,16,17- TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHRENE- 4-CARBOXYLIC ACID | B,D | 1AWH | 0.76 | |
CA4 | CYPROTERONE ACETATE | A | 2OZ7 | 0.71 | |
TH2 | TESTOSTERONE HEMISUCCINATE | A,B | 2CBT | 0.8 | |
TH2 | TESTOSTERONE HEMISUCCINATE | A,B,C,D,E,F | 2CBQ | 0.8 | |
TH2 | TESTOSTERONE HEMISUCCINATE | A | 2CBO | 0.8 | |
VDY | 3-{2-[1-(5-HYDROXY-1,5-DIMETHYL- HEXYL)-7A-METHYL-OCTAHYDRO-INDEN- 4-YLIDENE]-ETHYLIDENE}-4-METHYLENE- CYCLOHEXANOL | A,B | 1J78 | 0.71 | |
VDY | 3-{2-[1-(5-HYDROXY-1,5-DIMETHYL- HEXYL)-7A-METHYL-OCTAHYDRO-INDEN- 4-YLIDENE]-ETHYLIDENE}-4-METHYLENE- CYCLOHEXANOL | A,D | 1MZ9 | 0.71 | |
C33 | 2ALPHA-PROPYL-1ALPHA,25-DIHYDROXYVITAMIN D3 | A | 2HAM | 0.73 | |
C3O | 2ALPHA-PROPOXY-1ALPHA,25-DIHYDROXYVITAMIN D3 | A | 2HAS | 0.74 | |
ERG | ERGOSTEROL | A | 1BXM | 0.73 | |
ERG | ERGOSTEROL | A | 1ZHZ | 0.73 | |
ERG | ERGOSTEROL | A,B | 2AIB | 0.73 | |
ZK5 | 9ALPHA-FLUOROCORTISOL | A | 1GS4 | 0.72 | |
R18 | (17BETA)-17-HYDROXY-17-METHYLESTRA- 4,9,11-TRIEN-3-ONE | A | 1E3G | 0.78 | |
R18 | (17BETA)-17-HYDROXY-17-METHYLESTRA- 4,9,11-TRIEN-3-ONE | A,B | 1E3K | 0.78 | |
R18 | (17BETA)-17-HYDROXY-17-METHYLESTRA- 4,9,11-TRIEN-3-ONE | A | 2AO6 | 0.78 | |
R18 | (17BETA)-17-HYDROXY-17-METHYLESTRA- 4,9,11-TRIEN-3-ONE | A | 1XOW | 0.78 | |
R18 | (17BETA)-17-HYDROXY-17-METHYLESTRA- 4,9,11-TRIEN-3-ONE | A | 1XQ3 | 0.78 | |
HCY | (11alpha,14beta)-11,17,21-trihydroxypregn- 4-ene-3,20-dione | A,B | 2VDY | 0.74 | |
HCY | (11alpha,14beta)-11,17,21-trihydroxypregn- 4-ene-3,20-dione | A | 2V95 | 0.74 | |
VDX | 5-{2-[1-(5-HYDROXY-1,5-DIMETHYL- HEXYL)-7A-METHYL-OCTAHYDRO-INDEN- 4-YLIDENE]-ETHYLIDENE}-4-METHYLENE- CYCLOHEXANE-1,3-DIOL | A | 2ZBZ | 0.73 | |
VDX | 5-{2-[1-(5-HYDROXY-1,5-DIMETHYL- HEXYL)-7A-METHYL-OCTAHYDRO-INDEN- 4-YLIDENE]-ETHYLIDENE}-4-METHYLENE- CYCLOHEXANE-1,3-DIOL | A | 1RK3 | 0.73 | |
VDX | 5-{2-[1-(5-HYDROXY-1,5-DIMETHYL- HEXYL)-7A-METHYL-OCTAHYDRO-INDEN- 4-YLIDENE]-ETHYLIDENE}-4-METHYLENE- CYCLOHEXANE-1,3-DIOL | A | 1DB1 | 0.73 | |
VDX | 5-{2-[1-(5-HYDROXY-1,5-DIMETHYL- HEXYL)-7A-METHYL-OCTAHYDRO-INDEN- 4-YLIDENE]-ETHYLIDENE}-4-METHYLENE- CYCLOHEXANE-1,3-DIOL | A | 1IE9 | 0.73 | |
VDX | 5-{2-[1-(5-HYDROXY-1,5-DIMETHYL- HEXYL)-7A-METHYL-OCTAHYDRO-INDEN- 4-YLIDENE]-ETHYLIDENE}-4-METHYLENE- CYCLOHEXANE-1,3-DIOL | A | 2HC4 | 0.73 | |
VDX | 5-{2-[1-(5-HYDROXY-1,5-DIMETHYL- HEXYL)-7A-METHYL-OCTAHYDRO-INDEN- 4-YLIDENE]-ETHYLIDENE}-4-METHYLENE- CYCLOHEXANE-1,3-DIOL | A | 2ZLC | 0.73 | |
VDX | 5-{2-[1-(5-HYDROXY-1,5-DIMETHYL- HEXYL)-7A-METHYL-OCTAHYDRO-INDEN- 4-YLIDENE]-ETHYLIDENE}-4-METHYLENE- CYCLOHEXANE-1,3-DIOL | A | 3CV9 | 0.73 | |
P1A | 2,3,14,20,22-PENTAHYDROXYCHOLEST- 7-EN-6-ONE | A,D | 1R1K | 0.74 | |
P1A | 2,3,14,20,22-PENTAHYDROXYCHOLEST- 7-EN-6-ONE | E,U | 1Z5X | 0.74 | |
P1A | 2,3,14,20,22-PENTAHYDROXYCHOLEST- 7-EN-6-ONE | E,F,G,H | 2NXX | 0.74 | |
114 | COMPACTIN | A,B,C,D | 1HW8 | 0.83 | |
LVA | (3R,5R)-7-((1R,2R,6S,8R,8AS)-2,6- DIMETHYL-8-{[(2R)-2-METHYLBUTANOYL]OXY}- 1,2,6,7,8,8A-HEXAHYDRONAPHTHALEN- 1-YL)-3,5-DIHYDROXYHEPTANOIC ACID | A,B | 1T02 | 0.83 | |
MVB | (1S,7S,8S,8AR)-1,2,3,7,8,8A-HEXAHYDRO- 7-METHYL-8-[2-[(2R,4R)-TETRAHYDRO- 4-HY DROXY-6-OXO-2H-PYRAN-2-YL]ETHYL]- 1-NAPHTHALENOL | A,B,C | 1YA8 | 0.8 | |
CLR | CHOLESTEROL | A,B | 2ZXE | 0.71 | |
CLR | CHOLESTEROL | A | 1N83 | 0.71 | |
CLR | CHOLESTEROL | A | 2RH1 | 0.71 | |
CLR | CHOLESTEROL | A | 1LRI | 0.71 | |
CLR | CHOLESTEROL | A | 1ZHY | 0.71 | |
CLR | CHOLESTEROL | A | 3D4S | 0.71 | |
0CO | (1S,3R,5Z,7E,14beta,17alpha,23R)- 23-(2-hydroxy-2-methylpropyl)-20,24- epoxy-9,10-secochola-5,7,10-triene- 1,3-diol | A | 3CS6 | 0.75 | |
O1C | 2ALPHA-(3-HYDROXYPROPYL)-1ALPHA,25- DIHYDROXYVITAMIN D3 | A | 2HB7 | 0.74 | |
LAN | LANOSTEROL | A | 1W6K | 0.73 | |
VDZ | 5-{2-[1-(5-HYDROXY-1,5-DIMETHYL- HEXYL)-7A-METHYL-OCTAHYDRO-INDEN- 4-YLIDENE]-ETHYLIDENE}-2-METHYLENE- CYCLOHEXANE-1,3-DIOL | A | 1RJK | 0.73 | |
803 | LOVASTATIN | A,B | 1CQP | 0.81 | |
PRB | 13-ACETYLPHORBOL | A | 1PTR | 0.7 | |
HC3 | 25-HYDROXYCHOLESTEROL | A | 1ZHX | 0.73 | |
HC2 | 20-HYDROXYCHOLESTEROL | A | 1ZHW | 0.73 | |
C0R | CORTICOSTERONE | A | 2A3I | 0.72 | |
C0R | CORTICOSTERONE | A,B | 1Y5R | 0.72 | |
NTH | SUCCINIC ACID MONO-(13-METHYL-3- OXO-2,3,6,7,8,9,10,11,12,13,14,15,16,17- TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN- 17-YL) ESTER | A,B | 1BUQ | 0.79 | |
DL7 | (5beta,14beta,17alpha,25R)-3-oxocholest- 7-en-26-oic acid | A | 3GYU | 0.78 | |
ZBA | 12,13-Epoxytrichothec-9-ene-3,4,8,15- tetrol-4,15-diacetate-8-isovalerate | A | 2RKV | 0.73 | |
ZBA | 12,13-Epoxytrichothec-9-ene-3,4,8,15- tetrol-4,15-diacetate-8-isovalerate | A,B,C,D | 2ZBA | 0.73 | |
AND | 3-BETA-HYDROXY-5-ANDROSTEN-17-ONE | A,B | 1E3R | 0.78 | |
AND | 3-BETA-HYDROXY-5-ANDROSTEN-17-ONE | A | 3DHE | 0.78 | |
AND | 3-BETA-HYDROXY-5-ANDROSTEN-17-ONE | A | 1J99 | 0.78 | |
AND | 3-BETA-HYDROXY-5-ANDROSTEN-17-ONE | A | 1COY | 0.78 | |
AND | 3-BETA-HYDROXY-5-ANDROSTEN-17-ONE | A | 1Q22 | 0.78 | |
VD4 | (1R,3R,7E,17Z)-17-(5-hydroxy-1,5- dimethylhexylidene)-2-methylene- 9,10-secoestra-5,7-diene-1,3-diol | A | 2O4J | 0.71 | |
GA3 | GIBBERELLIN A3 | A | 2ZSH | 0.71 | |
GA3 | GIBBERELLIN A3 | A,B,C,D,E,F | 3ED1 | 0.71 | |
CO1 | 17-[3-(3,3-DIMETHYL-OXIRANYL)-1- METHYL-PROPYL]-10,13-DIMETHYL-2,3,4,7,8,9,10,11,12,13,14,15,16,17- TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN- 3-OL | A,B | 1P8D | 0.74 | |
FFA | (10ALPHA,13ALPHA,14BETA,17ALPHA)- 17-HYDROXYANDROST-4-EN-3-ONE | A,B | 2IPG | 0.74 | |
FFA | (10ALPHA,13ALPHA,14BETA,17ALPHA)- 17-HYDROXYANDROST-4-EN-3-ONE | A,B | 2IPJ | 0.74 | |
FFA | (10ALPHA,13ALPHA,14BETA,17ALPHA)- 17-HYDROXYANDROST-4-EN-3-ONE | A,B | 2IPF | 0.74 | |
MVD | 2ALPHA-METHYL-1ALPHA,25-DIHYDROXY- VITAMIN D3 | A | 2HB8 | 0.73 | |
DOG | DIGOXIGENIN | A | 1LKE | 0.75 | |
CBW | (3BETA,5BETA,14BETA)-3-HYDROXY- 11-OXOOLEAN-12-EN-29-OIC ACID | A | 2W4Q | 0.74 | |
DTX | DIGITOXIGENIN | A | 1LNM | 0.74 | |
JC1 | (1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)- 1-[(2S,3S)-3-(2-hydroxyethyl)heptan- 2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro- 1H-inden-4-ylidene]ethylidene]- 4-methylidene-cyclohexane-1,3-diol | A | 2ZXN | 0.72 |